Efficacy of a combined inactivated porcine reproductive and respiratory syndrome virus vaccine using North American and European strains in specific pathogen free pigs

被引:5
作者
Yeom, Minjoo [1 ,2 ]
Lyoo, Kwang-Soo [3 ]
Kang, Bo-Kyu [4 ]
Song, Daesub [1 ,2 ]
Park, Bongkyun [5 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Viral Infect Dis Res Ctr, Taejon 305806, South Korea
[2] Korea Univ, Coll Pharm, Dept Pharm, Sejong, South Korea
[3] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Iksan 561756, Jeonbuk, South Korea
[4] Green Cross Vet Prod, Res Unit, Yongin 449903, South Korea
[5] Seoul Natl Univ, Coll Vet Med, Dept Vet Med, Virol Lab, Seoul 151742, South Korea
关键词
Porcine reproductive and respiratory syndrome virus; Combined inactivated vaccine; PRRSV VACCINE; IMPACT; PROTECTION; ANTIBODIES;
D O I
10.1016/j.tvjl.2015.02.003
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
In Korea, porcine reproductive and respiratory syndrome (PRRS) is caused by European (type 1) and North American (type 2) strains of PRRS virus (PRRSV). In the present study, the efficacy of a multi-strain PRRSV vaccine inactivated with binary ethylenimine (BEI) was evaluated in pigs. The vaccine contained one type 1 strain (GCEU0907) and two type 2 strains (GC4019 and GC6262). Three vaccinated groups (four pigs per group) and three mock vaccinated groups (four pigs per group) were challenged with infectious PRRSV (strains GC4019, GC6262 or GCEU0907), then euthanased at 28 days post-infection. Mean anti-PRRSV neutralising antibody titres were significantly higher in the vaccinated groups than in the mock vaccinated groups. Mean blood virus titres in the mock vaccinated groups were significantly higher than those in the vaccinated groups from 5 to 28 days post-infection. On pathological examination, there were less severe macroscopic and microscopic lesions in vaccinated pigs compared with mock vaccinated pigs. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 50 条
  • [1] The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods
    Kim, Hyunil
    Kim, Hye Kwon
    Jung, Jung Ho
    Choi, Yoo Jung
    Kim, Jiho
    Um, Chang Gyu
    Hyun, Su Bin
    Shin, Sungho
    Lee, Byeongchun
    Jang, Goo
    Kang, Bo Kyu
    Moon, Hyoung Joon
    Song, Dae Sub
    VIROLOGY JOURNAL, 2011, 8
  • [2] Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virus
    PlanaDuran, J
    Bastons, M
    Urniza, A
    Vayreda, M
    Vila, X
    Mane, H
    VETERINARY MICROBIOLOGY, 1997, 55 (1-4) : 361 - 370
  • [3] Recombination between North American strains of porcine reproductive and respiratory syndrome virus
    Yuan, SS
    Nelsen, CJ
    Murtaugh, MP
    Schmitt, BJ
    Faaberg, KS
    VIRUS RESEARCH, 1999, 61 (01) : 87 - 98
  • [4] Immune responses induced by inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in neonatal pigs using different adjuvants
    Vreman, Sandra
    Stockhofe-Zurwieden, Norbert
    Popma-de Graaf, Ditta J.
    Savelkoul, Huub F. J.
    Barnier-Quer, C.
    Collin, N.
    Collins, Damien
    McDaid, Dennis
    Moore, Anne C.
    Rebel, Johanna M. J.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2021, 232
  • [5] Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy
    Labarque, G
    Van Reeth, K
    Nauwynck, H
    Drexler, C
    Van Gucht, S
    Pensaert, M
    VACCINE, 2004, 22 (31-32) : 4183 - 4190
  • [6] Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
    Sanchez-Matamoros, Almudena
    Camprodon, Agusti
    Maldonado, Jaime
    Pedrazuela, Rafael
    Miranda, Joel
    PORCINE HEALTH MANAGEMENT, 2019, 5 (1)
  • [7] Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets
    Drexler, C. S.
    Witvliet, M. H.
    Raes, M.
    van de Laar, M.
    Eggen, A. A. S.
    Thacker, E. L.
    VETERINARY RECORD, 2010, 166 (03) : 70 - 74
  • [8] Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena
    Trus, Ivan
    Bonckaert, Caroline
    van der Meulen, Karen
    Nauwynck, Hans J.
    VACCINE, 2014, 32 (25) : 2995 - 3003
  • [9] Enhancing immunogenicity and antiviral protection of inactivated porcine reproductive and respiratory syndrome virus vaccine in piglets
    Wang, Bing-Lei
    Zhang, Shuai
    Liu, Ying
    Zhao, Yun-Huan
    Wang, Chuan-Wen
    Li, Yan
    Zuo, Yu-Zhu
    Fan, Jing-Hui
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2024, 85 (08)
  • [10] The potential adjuvanticity of quaternized chitosan hydrogel based microparticles for porcine reproductive and respiratory syndrome virus inactivated vaccine
    Wang, Yue-Qi
    Liu, Yan
    Wang, Yu-Xia
    Wu, Ya-Jun
    Jia, Pei-Yuan
    Shan, Jun-Jie
    Wu, Jie
    Ma, Guang-Hui
    Su, Zhi-Guo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 39 : 84 - 91